Medicenna Therapeutics Corp.
Stock Forecast, Prediction & Price Target

Medicenna Therapeutics Corp. Financial Estimates

Medicenna Therapeutics Corp. Revenue Estimates

Medicenna Therapeutics Corp. EBITDA Estimates

Medicenna Therapeutics Corp. Earnings per Share Estimates

Passed Analyst forecast
Metric 3/31/2021 3/31/2022 3/31/2023 3/31/2026 3/31/2027
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $1.37M
Low: $1.55M
High: $1.12M
avg. 0%
Avg: $600K
Low: $676.43K
High: $492.99K
avg. -56.36%
Net Income
 
% change YoY
$-17.18M
 
N/A
$-22.64M
 
-31.79%
$1.54M
 
106.83%
Avg: $-23.46M
Low: $-18.77M
High: $-12.94M
avg. -1616.69%
Avg: $-19.55M
Low: $-22.66M
High: $-15.19M
avg. 16.67%
EBITDA
 
% change YoY
$-17.14M
 
N/A
$-22.26M
 
-29.83%
$-16.29M
 
26.78%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$0.35
 
N/A
-$0.42
 
-20.00%
$0.02
 
105.69%
Avg: -$0.25
Low: -$0.29
High: -$0.2
avg. -1146.02%
Avg: -$0.3
Low: -$0.35
High: -$0.23
avg. -20.79%
Operating Expenses
 
% change YoY
$17.39M
 
N/A
$22.47M
 
29.19%
$16.30M
 
-27.45%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Medicenna Therapeutics Corp. stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -800.00% in 2026-2027.

We have gathered data from 4 analysts. Their low estimate is -18.77M, average is -23.46M and high is -12.94M.

What is Medicenna Therapeutics Corp. stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of -28.18% in 2026-2027.

We have gathered data from 4 analysts. Their low revenue estimate is $1.55M, average is $1.37M and high is $1.12M.

What is Medicenna Therapeutics Corp. stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of -583.41% in 2026-2027.

We have gathered data from 4 analysts. Their low earnings per share estimate is -$0.29, average is -$0.25 and high is $-0.2.